Expression profiling of macrophages reveals multiple populations with distinct biological roles in an immunocompetent orthotopic model of lung cancer

Journal of Immunology

Volumn 196, Issue 6, 2016, Pages 2847-2859

  Poczobutt, Joanna M ^a   De, Subhajyoti ^a   Yadav, Vinod K ^a   Nguyen, Teresa T ^a   Li, Howard ^a,b   Sippel, Trisha R ^a   Weiser Evans, Mary C M ^a   Nemenoff, Raphael A ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER MODEL; CANCER PROGNOSIS; CANCER STAGING; CELL COUNT; CELL FUNCTION; CELL POPULATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOCOMPETENCE; LIPID METABOLISM; LUNG ADENOCARCINOMA; LUNG ALVEOLUS; LUNG CANCER CELL LINE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; TUMOR MICROENVIRONMENT; ADENOCARCINOMA; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CARCINOGENESIS; DISEASE MODEL; EXTRACELLULAR MATRIX; GENETICS; IMMUNOLOGY; LUNG ALVEOLUS MACROPHAGE; LUNG NEOPLASMS; METABOLISM; MONOCYTE; PHYSIOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CHEMOKINES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; IMMUNOCOMPETENCE; LIPID METABOLISM; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MONOCYTES; NEOPLASM TRANSPLANTATION; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84962563570     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502364     Document Type: Article

References (44)

1. Jemal, A., R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M. J. Thun. 2008. Cancer statistics, 2008. CA Cancer J. Clin. 58:71-96.
2. Kenny, P. A., G. Y. Lee, and M. J. Bissell. 2007. Targeting the tumor microenvironment. Front. Biosci. 12:3468-3474.
3. Noy, R., and J. W. Pollard. 2014. Tumor-associated macrophages: from mechanisms to therapy. Immunity 41:49-61.
4. Zaynagetdinov, R., T. P. Sherrill, V. V. Polosukhin, W. Han, J. A. Ausborn, A. G. McLoed, F. B. McMahon, L. A. Gleaves, A. L. Degryse, G. T. Stathopoulos, et al. 2011. A critical role for macrophages in promotion of urethane-induced lung carcinogenesis. J. Immunol. 187:5703-5711.
5. Sharma, S. K., N. K. Chintala, S. K. Vadrevu, J. Patel, M. Karbowniczek, and M. M. Markiewski. 2015. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J. Immunol. 194:5529-5538.
6. Remark, R., C. Becker, J. E. Gomez, D. Damotte, M. C. Dieu-Nosjean, C. Sautès-Fridman, W. H. Fridman, C. A. Powell, N. K. Altorki, M. Merad, and S. Gnjatic. 2015. The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome. Am. J. Respir. Crit. Care Med. 191:377-390.
7. Allavena, P., A. Sica, G. Solinas, C. Porta, and A. Mantovani. 2008. The inflammatory micro-environment in tumor progression: the role of tumorassociated macrophages. Crit. Rev. Oncol. Hematol. 66:1-9.
8. Mantovani, A., S. Sozzani, M. Locati, P. Allavena, and A. Sica. 2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:549-555.
9. Immunological Genome Consortium. 2012. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13:1118-1128.
10. Poczobutt, J. M., M. Gijon, J. Amin, D. Hanson, H. Li, D. Walker, M. Weiser-Evans, X. Lu, R. C. Murphy, and R. A. Nemenoff. 2013. Eicosanoid profiling in an orthotopic model of lung cancer progression by mass spectrometry demonstrates selective production of leukotrienes by inflammatory cells of the microenvironment. PLoS One 8:e79633.
11. Trapnell, C., L. Pachter, and S. L. Salzberg. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105-1111.
12. Langmead, B., C. Trapnell, M. Pop, and S. L. Salzberg. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10:R25.
13. Trapnell, C., D. G. Hendrickson, M. Sauvageau, L. Goff, J. L. Rinn, and L. Pachter. 2013. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 31:46-53.
14. Robinson, M. D., D. J. McCarthy, and G. K. Smyth. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26:139-140.
15. De Hoon, M. J., S. Imoto, J. Nolan, and S. Miyano. 2004. Open source clustering software. Bioinformatics 20:1453-1454.
16. Saldanha, A. J. 2004. Java Treeview-extensible visualization of microarray data. Bioinformatics 20:3246-3248.
17. Kamburov, A., K. Pentchev, H. Galicka, C. Wierling, H. Lehrach, and R. Herwig. 2011. ConsensusPathDB: toward a more complete picture of cell biology. Nucleic Acids Res. 39:D712-D717.
18. Kamburov, A., C. Wierling, H. Lehrach, and R. Herwig. 2009. ConsensusPathDB-a database for integrating human functional interaction networks. Nucleic Acids Res. 37:D623-D628.
19. Huang, W., B. T. Sherman, and R. A. Lempicki. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4:44-57.
20. Huang, W., B. T. Sherman, and R. A. Lempicki. 2009. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37:1-13.
21. The Gene Ontology Consortium. 2000. Gene Ontology: tool for the unification of biology. Nat. Genet. 25:25-29.
22. Boyle, E. I., S. Weng, J. Gollub, H. Jin, D. Botstein, J. M. Cherry, and G. Sherlock. 2004. GO: TermFinder-open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 20:3710-3715.
23. Mootha, V. K., C. M. Lindgren, K. F. Eriksson, A. Subramanian, S. Sihag, J. Lehar, P. Puigserver, E. Carlsson, M. Ridderstråle, E. Laurila, et al. 2003. PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34:267-273.
24. Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. Pomeroy, T. R. Golub, E. S. Lander, and J. P. Mesirov. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102:15545-15550.
25. Duan, M., W. C. Li, R. Vlahos, M. J. Maxwell, G. P. Anderson, and M. L. Hibbs. 2012. Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. J. Immunol. 189:946-955.
26. Janssen, W. J., L. Barthel, A. Muldrow, R. E. Oberley-Deegan, M. T. Kearns, C. Jakubzick, and P. M. Henson. 2011. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am. J. Respir. Crit. Care Med. 184:547-560.
27. Stevens, W. W., T. S. Kim, L. M. Pujanauski, X. Hao, and T. J. Braciale. 2007. Detection and quantitation of eosinophils in the murine respiratory tract by flow cytometry. J. Immunol. Methods 327:63-74.
28. 7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176:2161-2172.
29. Zhang, J. Q., B. Biedermann, L. Nitschke, and P. R. Crocker. 2004. The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils. Eur. J. Immunol. 34:1175-1184.
30. + pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J. Exp. Med. 208:1789-1797.
31. Becher, B., A. Schlitzer, J. Chen, F. Mair, H. R. Sumatoh, K. W. Teng, D. Low, C. Ruedl, P. Riccardi-Castagnoli, M. Poidinger, et al. 2014. Highdimensional analysis of the murine myeloid cell system. Nat. Immunol. 15:1181-1189.
32. Immunological Genome Project Consortium. 2008. The Immunological Genome Project: networks of gene expression in immune cells. Nat. Immunol. 9:1091-1094.
33. Wang, D., and R. N. Dubois. 2010. Eicosanoids and cancer. Nat. Rev. Cancer 10:181-193.
34. Dennis, E. A., and P. C. Norris. 2015. Eicosanoid storm in infection and inflammation. Nat. Rev. Immunol. 15:511-523.
35. 2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis. Cancer Res. 69:1733-1738.
36. Liao, C., Z. Yu, W. Guo, Q. Liu, Y. Wu, Y. Li, and L. Bai. 2014. Prognostic value of circulating inflammatory factors in non-small cell lung cancer: a systematic review and meta-analysis. Cancer Biomark. 14:469-481.
37. Balkwill, F. R. 2012. The chemokine system and cancer. J. Pathol. 226:148-157.
38. Hynes, N. E., and H. A. Lane. 2005. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 5:341-354.
39. Ricard-Blum, S. 2011. The collagen family. Cold Spring Harb. Perspect. Biol. 3:a004978.
40. Theocharis, S., J. Klijanienko, C. Giaginis, J. Rodriguez, T. Jouffroy, A. Girod, D. Point, G. Tsourouflis, and X. Satre-Garau. 2011. Peroxisome proliferatoractivated receptor-γ in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival. J. Cancer Res. Clin. Oncol. 137:251-259.
41. Lu, P., V. M. Weaver, and Z. Werb. 2012. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196:395-406.
42. Murray, P. J., J. E. Allen, S. K. Biswas, E. A. Fisher, D. W. Gilroy, S. Goerdt, S. Gordon, J. A. Hamilton, L. B. Ivashkiv, T. Lawrence, et al. 2014. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41:14-20.
43. Gentles, A. J., A. M. Newman, C. L. Liu, S. V. Bratman, W. Feng, D. Kim, V. S. Nair, Y. Xu, A. Khuong, C. D. Hoang, et al. 2015. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat. Med. 21:938-945.
44. Welsh, T. J., R. H. Green, D. Richardson, D. A. Waller, K. J. O'Byrne, and P. Bradding. 2005. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J. Clin. Oncol. 23:8959-8967.